Emerging Pharma Leadership Awards - Elizabeth Mutisya

Article

Elizabeth Mutisya, VP, US Medical Affairs, CMO, Solvay Pharmaceuticals
Download Adobe Flash Player

“We need to do a better job of delineating the value our industry provides in addressing medical problems. Health economics allows us to better quantify the benefits of our solutions to patient outcomes, health-related quality of life, and individuals involved in patient care.” Listen to the Podcast for more coverage.

Recent Videos
Fred Aslan
Dr. Dina Radenkovic, CEO, Gameto
Recent Regulatory Impacts on the Pain-Management Space
Fred Aslan
Fred Aslan
Fred Aslan
Related Content